Ashokkumar B. Patel

Array ( [id] => 7089797 [patent_doc_number] => 20050009910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug' [patent_app_type] => utility [patent_app_number] => 10/617468 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5973 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009910.pdf [firstpage_image] =>[orig_patent_app_number] => 10617468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270428 [patent_doc_number] => 20040058946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Abuse-resistant prodrugs of oxycodone and other pharmaceuticals' [patent_app_type] => new [patent_app_number] => 10/613742 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10684 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058946.pdf [firstpage_image] =>[orig_patent_app_number] => 10613742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311110 [patent_doc_number] => 07528134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Acetamides and benzamides that are useful in treating sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 10/444687 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 116161 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528134.pdf [firstpage_image] =>[orig_patent_app_number] => 10444687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837060 [patent_doc_number] => 07393875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Methods and compounds for inhibiting amyloid deposits' [patent_app_type] => utility [patent_app_number] => 10/429198 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6145 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393875.pdf [firstpage_image] =>[orig_patent_app_number] => 10429198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534812 [patent_doc_number] => 07888372 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Compositions and methods for modulating bone mineral deposition' [patent_app_type] => utility [patent_app_number] => 10/426005 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28639 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888372.pdf [firstpage_image] =>[orig_patent_app_number] => 10426005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5630948 [patent_doc_number] => 20060147416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Method of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myelodysplastic syndromes' [patent_app_type] => utility [patent_app_number] => 10/531552 [patent_app_country] => US [patent_app_date] => 2003-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16233 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147416.pdf [firstpage_image] =>[orig_patent_app_number] => 10531552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643365 [patent_doc_number] => 20060281820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Lfa-1 inhibitors and use thereof' [patent_app_type] => utility [patent_app_number] => 10/545024 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22255 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281820.pdf [firstpage_image] =>[orig_patent_app_number] => 10545024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6663694 [patent_doc_number] => 20030203020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Pharmaceutical compositions for piperidinoalkanol compounds' [patent_app_type] => new [patent_app_number] => 10/347953 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14919 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203020.pdf [firstpage_image] =>[orig_patent_app_number] => 10347953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103412 [patent_doc_number] => 20050106138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Specific depletion of cd4+ t cells' [patent_app_type] => utility [patent_app_number] => 10/488548 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 11440 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106138.pdf [firstpage_image] =>[orig_patent_app_number] => 10488548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088580 [patent_doc_number] => 20050008692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Compositions comprising pectin and ascorbic acid' [patent_app_type] => utility [patent_app_number] => 10/488451 [patent_app_country] => US [patent_app_date] => 2002-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1420 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008692.pdf [firstpage_image] =>[orig_patent_app_number] => 10488451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046975 [patent_doc_number] => 20020168424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma' [patent_app_type] => new [patent_app_number] => 10/064627 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3469 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168424.pdf [firstpage_image] =>[orig_patent_app_number] => 10064627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461030 [patent_doc_number] => 07879869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Drugs for ameliorating postcibal hyperglycemia' [patent_app_type] => utility [patent_app_number] => 10/485217 [patent_app_country] => US [patent_app_date] => 2002-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2655 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879869.pdf [firstpage_image] =>[orig_patent_app_number] => 10485217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846459 [patent_doc_number] => 20080182867 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2008-07-31 [patent_title] => 'O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders' [patent_app_type] => utility [patent_app_number] => 10/192193 [patent_app_country] => US [patent_app_date] => 2002-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11145 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0182/20080182867.pdf [firstpage_image] =>[orig_patent_app_number] => 10192193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846459 [patent_doc_number] => 20080182867 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2008-07-31 [patent_title] => 'O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders' [patent_app_type] => utility [patent_app_number] => 10/192193 [patent_app_country] => US [patent_app_date] => 2002-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11145 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0182/20080182867.pdf [firstpage_image] =>[orig_patent_app_number] => 10192193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200852 [patent_doc_number] => 20050165053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/477953 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12026 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165053.pdf [firstpage_image] =>[orig_patent_app_number] => 10477953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651054 [patent_doc_number] => 20030105007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds' [patent_app_type] => new [patent_app_number] => 10/145678 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10798 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105007.pdf [firstpage_image] =>[orig_patent_app_number] => 10145678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865932 [patent_doc_number] => 20030191458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Light-activated drug delivery method and device' [patent_app_type] => new [patent_app_number] => 10/116699 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13044 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191458.pdf [firstpage_image] =>[orig_patent_app_number] => 10116699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818259 [patent_doc_number] => 20030069217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Methods of prevention and treatment of ischemic damage' [patent_app_type] => new [patent_app_number] => 10/082812 [patent_app_country] => US [patent_app_date] => 2002-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10643 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069217.pdf [firstpage_image] =>[orig_patent_app_number] => 10082812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745673 [patent_doc_number] => 20030022856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Method for sustained release local delivery of drugs for ablation of unwanted tissue' [patent_app_type] => new [patent_app_number] => 10/058835 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7047 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022856.pdf [firstpage_image] =>[orig_patent_app_number] => 10058835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7452923 [patent_doc_number] => 20040067895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Kahalalide f formulation' [patent_app_type] => new [patent_app_number] => 10/399571 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3329 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067895.pdf [firstpage_image] =>[orig_patent_app_number] => 10399571 [rel_patent_id] =>[rel_patent_doc_number] =>)